[Propiramfumarate in a clinical study].
D000577:Amides / Q000009:adverse effects / Q000627:therapeutic use*; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D003085:Colic / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D005650:Fumarates / Q000009:adverse effects / Q000627:therapeutic use; D006261:Headache / Q000188:drug therapy; D006801:Humans; D008297:Male; D009437:Neuralgia / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D010149:Postoperative Pain / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D012494:Sampling Studies; D013488:Suppositories
D000577:Amides; D000700:Analgesics; D005650:Fumarates; D010880:Piperidines; D011422:Propionates; D011725:Pyridines; D013488:Suppositories
Propiramfumarat in der Klinischen Prüfung